Bullish
TD Asset Management Inc. reduced its stake in CVS Health Corporation by 3.0% in the fourth quarter of the prior year, selling 38,412 shares but still ...
CVS Health highlights the critical need to shift focus in mental health care from just access to also measuring the quality and effectiveness of treat...
Neutral
CVS Pharmacy is utilizing advanced automation in its distribution centers, such as the one in Hainesport, New Jersey, to enhance the efficiency and pr...
Neutral
Natixis Advisors LLC recently reduced its stake in CVS Health Corporation by 4.2% in the fourth quarter, selling 55,533 shares, though institutional i...
Bullish
MUFG Securities EMEA plc significantly increased its stake in CVS Health Corporation, acquiring an additional 95,736 shares during the fourth quarter,...
Bullish
Savant Capital LLC significantly reduced its stake in CVS Health Corporation, selling 35,002 shares and decreasing its holdings by 47.5%. Other instit...
Neutral
Kingsview Wealth Management LLC significantly reduced its stake in CVS Health Corporation by 65.5% in the fourth quarter, selling 68,425 shares. Despi...
Neutral
Foundations Investment Advisors LLC significantly increased its holdings in CVS Health Corporation (NYSE:CVS) during the fourth quarter, purchasing an...
Debbie Kim, a Health Coach nurse on the Social Risk Factors team at CVS Health, helps Medicare members overcome both clinical and social barriers to c...
Bullish
CVS Caremark announced it will reinstate Zepbound (tirzepatide) to its commercial formularies as a preferred option and remove the new-to-market block...
Bullish
CVS Health received the 2026 Newsweek AI Impact Award in the AI Health Care category for Best Outcomes – Patient Care. The award recognizes CVS Health...
Bullish
National Pension Service reduced its stake in CVS Health Corporation by 17.0% in the fourth quarter, selling over 678,000 shares. Despite this, other ...
CVS Caremark is reinstating coverage for Eli Lilly's obesity medications, Zepbound and the new oral GLP-1, Foundayo, despite previously favoring Novo ...
Bullish
CVS Health is enhancing its call center operations by integrating Salesforce artificial intelligence technology, specifically Agentforce Health, acros...
Neutral
CVS Caremark has reinstated coverage for Eli Lilly's weight-loss drug, Zepbound, effective October 1, and will add Foundayo to its formularies on June...
Bullish
World Investment Advisors significantly increased its stake in CVS Health Corporation by 36.5% in the fourth quarter, bringing its total holdings to 7...
CVS Health and Salesforce have expanded their collaboration, leveraging Salesforce’s Agentforce Health to enhance call center personalization for mill...
Bullish
Salesforce and CVS Health are expanding their long-standing collaboration by implementing Salesforce's AI-powered Agentforce Health solution in CVS ca...
Bullish
CVS Health announced updates to its commercial formularies, expanding options for GLP-1 weight management medications. CVS Caremark will add Zepbound ...
Bullish
CVS Health announced it will re-add Eli Lilly's weight-loss drug Zepbound to some of its drug lists for insurance coverage, effective October 1. This ...